• HOME
  • Topical Steroid-Free Investigational Medication for Eczema in Adults and Adolescents

Topical Steroid-Free Investigational Medication for Eczema in Adults and Adolescents

A research study is now enrolling adults and adolescents with mild to moderate atopic dermatitis (also called eczema). If you or your adolescent child has eczema, he or she may be eligible for a research study involving an investigational topical non-steroidal drug.

Qualified participants will receive study-related medical evaluations and study drug at no cost along with compensation for their time. Medical insurance is not required to participate.

PARTICIPATING CITIES

Fremont, CA Contact Fremont Office
Los Angeles, CA Contact Los Angeles Office
San Diego, CA Contact San Diego Office
San Luis Obispo, CA Contact San Luis Obispo Office
Louisville, KY Contact Louisville Office 1 | Contact Louisville Office 2
High Point, NC Contact High Point Office
Berlin, NJ Contact Berlin Office
Portland, OR Contact Portland Office
Dallas, TX Contact Dallas Office
Houston, TX Contact Houston Office 1 | Contact Houston Office 2
San Antonio, TX Contact San Antonio Office
Norfolk, VA Contact Norfolk Office

Additional sites may be added.

LEARN MORE
For more about the study drug RVT-501, please call 929-227-3826 or e-mail: RVT-501study@roivant.com.

To read more about the study on the U.S. National Institutes of Health website, please visit: clinicaltrials.gov.

The National Eczema Association (NEA) announces research clinical trials as an informational service.  This announcement does not represent a NEA endorsement of the study, but makes you aware that it is available for your participation.